Pricing Log in Create free account
Friday 6 November 2026 Export IOVA’s income statement to Excel — free account

Iovance Biotherapeutics, Inc.

IOVA Healthcare Biotechnology

Iovance Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $263.5 million, up 60.6% from fiscal 2024.

Revenue
+80.1%
EPS
+80.0%
Free cash flow
+89.7%

Quarter to September 2026, against a year earlier

7.99 0.25 +3.23%
Market cap
$3.5B
P/E
0.0×
Fwd P/E
−18.9×
Dividend yield
—
F-score
4/9
Altman Z
−2.30
Beneish M
−2.46
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Iovance Biotherapeutics, Inc. (IOVA) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Iovance Biotherapeutics, Inc. (IOVA) trades at a EV/FCF of −14.9×. Over the past ten years it has ranged from −31.0× (March 2015) to −0.5× (May 2025); the current reading is higher than 20% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 −2.0× —
FY2024 −5.0× —
FY2023 −4.2× —

Quarterly newest first

Period EV/FCF Change
Sep 2026 −29.5× —
Jun 2026 −5.3× —
Mar 2026 −3.8× —
Dec 2025 −2.0× —
10 more quarters

Against its own ten years

Low −31.0× High −0.5×
Ten-year median −7.5×
Current reading's percentile 20

EV/FCF against peers

Company EV/FCF
EWTX Edgewise Therapeutics, Inc. compare −23.6×
ABCL AbCellera Biologics Inc. compare −23.4×
ACAD ACADIA Pharmaceuticals Inc. compare −23.3×
TNGX Tango Therapeutics, Inc. compare −15.0×
IOVA Iovance Biotherapeutics, Inc. −14.9×
IRON Disc Medicine, Inc. compare −12.1×
RLAY Relay Therapeutics, Inc. compare −12.0×
XENE Xenon Pharmaceuticals Inc. compare −8.5×
PBLS Parabilis Medicines, Inc. compare 2.6×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on IOVA